Effects of eugenol on T-type Ca2+ channel isoforms
Haengsoo Seo1, Hai Ying Li, Edward Perez-Reyes
1Department of Life Science and Basic Science Institute for Cell Damage Control, Sogang University, Seoul, Republic of Korea (H.S., H.Y.L., J.-H.L.); and Department of Pharmacology, University of Virginia, Charlottesville, Virginia (E.P.-R.).
Eugenol, a dental analgesic, inhibits T-type calcium channels (Cav3.1, Cav3.2, Cav3.3) in neurons. This study identifies these channels as new molecular targets for eugenol's pain-relieving effects.
Area of Science:
- Neuroscience
- Pharmacology
- Molecular Biology
Background:
- Eugenol is a known dental analgesic.
- Its analgesic effects are linked to voltage-gated sodium and high-voltage-activated calcium channels in trigeminal ganglion neurons.
- The impact of eugenol on T-type calcium channels in afferent neurons remained unexplored.
Purpose of the Study:
- To investigate the influence of eugenol on cloned T-type calcium channel isoforms (Cav3.1, Cav3.2, Cav3.3).
- To determine if T-type calcium channels are molecular targets for eugenol's analgesic properties.
Main Methods:
- Whole-cell patch clamp electrophysiology was used to study cloned T-type channel isoforms expressed in HEK293 cells.
- T-type currents from rat trigeminal ganglion neurons were also recorded and analyzed.
Main Results:
- Eugenol inhibited Cav3.1, Cav3.2, and Cav3.3 currents in a concentration-dependent manner (IC50 values: 463, 486, and 708 μM, respectively).
- Eugenol negatively shifted steady-state inactivation curves but not activation curves of T-type channels.
- Eugenol accelerated Cav3.3 inactivation kinetics and showed use-dependent inhibition, with similar potency observed in rat trigeminal ganglion neurons.
Conclusions:
- T-type calcium channels (Cav3.1, Cav3.2, Cav3.3) are identified as novel molecular targets of eugenol.
- These findings provide a deeper understanding of eugenol's analgesic mechanisms in dental pain.
- Eugenol's interaction with T-type channels contributes to its pain-relieving effects.
Related Concept Videos
Ligand-Gated Ion Channel Receptor: Gating Mechanism
Voltage-gated Ion Channels
Generally, all voltage-gated ion channels have a 'voltage-sensing domain' that spans the lipid bilayer. The charged residues in the sensor move in response to the membrane potential changes that open the channel allowing ions movement. There are several types of...
Calmodulin-dependent Signaling
The Ca2+-CaM complex does not have enzymatic activity by itself. Instead, the complex binds downstream target proteins, including membrane proteins or enzymes,...
G-Protein Gated Ion Channels
Sensory organs,...
Antiepileptic Drugs: Calcium Channel Blockers
Calcium channel blockers exert their antiepileptic effects by targeting T-type calcium channels, which are integral to transmitting nerve signals in the central nervous system. These channels allow the passage of calcium ions, which are vital for neuronal communication. By inhibiting T-type calcium channels, calcium channel blockers effectively reduce the release of neurotransmitters and...
Feedback Regulation of Calcium Concentration
Various transmembrane receptors, such as G protein-coupled receptors (GPCRs), elicit a response to extracellular signals by increasing cytosolic calcium. Activated GPCRs...


